A second choice of rotavirus vaccine has been added to the childhood immunization schedule. Rotarix oral rotavirus vaccine (RV1) has been added to updated recommendations from the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention for prevention of rotavirus gastroenteritis. ACIP does not express a preference for Rotarix or RotaTeq oral vaccine (RV5), which was approved earlier. The complete, updated recommendations were published February 6 in Morbidity and Mortality Weekly Report.
< Previous Article | Next Article >